Each week on Saturday morning, the NeurologyLive® team puts together a weekly recap that offers a quick look into some of the top headlines in neurology news that you may have missed.
Topline Data on NE3017 Announced, Pitolisant Improves EDS in DM1, Nerivio Reduces Migraine Treatment Days
Neurology News Network for the week ending December 16, 2023. [WATCH TIME: 3 minutes]
Concomitant ASM Dosages With Stiripentol, FDA Pushes Givinostat Decision Back, Soticlestat Improves Caregiver Satisfaction
Neurology News Network for the week ending December 9, 2023. [WATCH TIME: 3 minutes]
Phase 2 Trial of Alzheimer Psychosis Initiated, FDA Declines to Lift Hold on ENTR-601-44, Levetiracetam and Clobazam With Safety Warnings
Neurology News Network for the week ending December 1, 2023. [WATCH TIME: 4 minutes]
FDA Grants BrainStorm Meeting for NurOwn, Gene Therapy Study of AB-1005 Underway, VISION Trial to Test DBS Enhancement in PD
Neurology News Network for the week ending November 25, 2023. [WATCH TIME: 4 minutes
Valbenazine Shines in Open-Label Extension, FDA Grants Breakthrough Designation to NfL Test, Tocilizumab Effective in NMOSD
Neurology News Network for the week ending November 18, 2023. [WATCH TIME: 3 minutes]
FDA Clears Modius Sleep Device, NDA Accepted for SPN-830, Zilucoplan Improves Myasthenic Fatigue
Neurology News Network for the week ending November 11, 2023. [WATCH TIME: 3 minutes]
Migraine Preventive Prescription Trends, TAK-861 Phase 1 Study in Narcolepsy, Simufilam Not Associated With ARIA-E
Neurology News Network for the week ending November 4, 2023. [WATCH TIME: 3 minutes]
Solanezumab Fails A4 Alzheimer Study, FDA Lifts Hold on FREEDOM-DM1 Trial, CMS Announces Coverages of PET Amyloid-ß Imaging
Neurology News Network for the week ending October 21, 2023. [WATCH TIME: 3 minutes]
FDA Hands CRL to Patisiran, GBA1 Parkinson Trial Initiated, Levetiracetam Effective as First-Line Treatment in IGE Syndromes
Neurology News Network for the week ending October 14, 2023. [WATCH TIME: 3 minutes]
FDA Clears High Dose Cohort of CTI-1601, SOMNUM AI Device Approved, Intracranial Pressure Monitoring and TBI
Neurology News Network for the week ending October 7, 2023. [WATCH TIME: 3 minutes]
AdComm Committee Downvotes NurOwn, ADELY01 Cleared for Trials, Axsome Pushes Back SYMPHONY Trial
Neurology News Network for the week ending September 30, 2023. [WATCH TIME: 4 minutes]
FDA Approves AIRAscore, Pimavanserin Packing Label Updated, Blarcamesine Data Released
Neurology News Network for the week ending September 23, 2023. [WATCH TIME: 3 minutes]
MS Treatments Linked With PML, Neflamapimod Effectiveness Based on P-Tau181 Levels, Nerivio Safe in Pregnant Women
Neurology News Network for the week ending September 16, 2023. [WATCH TIME: 3 minutes]
CNM-Au8 Improves Survival in ALS, New Parkinson Risk Factor Identified, Pamrevlumab Falls Short in Phase 3 Study
Neurology News Network for the week ending September 9, 2023. [WATCH TIME: 3 minutes]
Cell Therapy Bemdaneprocel Meets Primary Objective, Retinal Thickness in Parkinson Disease, TERIS Study Findings Published
Neurology News Network for the week ending September 2, 2023. [WATCH TIME: 3 minutes]
DT-216 Reduces Frataxin Levels in FA, Valbenazine FDA-Approved for Huntington Chorea, EU Approves Atogepant as Migraine Preventive
Neurology News Network for the week ending August 26, 2023. [WATCH TIME: 3 minutes]
FDA Approves DaxibotulinumtoxinA for Cervical Dystonia, Genetic Parkinson Trial Announced, DBS Improves Poststroke Mobility
Neurology News Network for the week ending August 19, 2023. [WATCH TIME: 4 minutes]
Vyvgart Hytrulo Meets Primary End Point, Trial on Fibromyalgia-Type Long COVID Continues, Aspirin Increased Intracranial Bleeding in Elders
Neurology News Network for the week ending August 12, 2023. [WATCH TIME: 3 minutes]
MS Medications Added to WHO Essential List, Epigenome Therapy Shows Efficacy in AD, Phase 3 NEURO-TTransform Results Announced
Neurology News Network for the week ending August 5, 2023. [WATCH TIME: 4 minutes]
Positive Data on Dravet Therapy STK-001, FDA Clears Zoom 88 LDP Support, MS Diagnostic Guidelines Updated
Neurology News Network for the week ending July 29, 2023. [WATCH TIME: 4 minutes]
TRAILBLAZER-ALZ-2 Data of Donanemab Published, Risdiplam Effective in SMA up to 4 Years, Preclinical Alzheimer Study of Lecanemab Announced
Neurology News Network for the week ending July 22, 2023. [WATCH TIME: 3 minutes]
Sleeping Pills and Increased Mortality, IPX203 Receives CRL, CT1812 Impacts Brain Function
Neurology News Network for the week ending July 8, 2023. [WATCH TIME: 3 minutes]
Gene Therapy AMT-130 in Huntington Disease, NDA Submitted for Troriluzole in Spinocerebellar Ataxia, FDA Clears Alzheimer Assays
Neurology News Network for the week ending July 1, 2023. [WATCH TIME: 3 minutes]
CNM-Au8 Reduces Neurofilament Light, Candesartan Benefits Headache, Ketamine Shows Potential in Migraine
Neurology News Network for the week ending June 24, 2023. [WATCH TIME: 3 minutes]
Phase 3 LAVENDER Trial Results Published, Protective and Risk Factors of Insomnia, Lecanemab Gets Positive FDA AdComm Review
Neurology News Network for the week ending June 17, 2023. [WATCH TIME: 3 minutes]
BIIB122 Discontinued in LRRK2 Parkinson Disease, Pimavanserin and PTSD-Associated Insomnia, Obstructive Sleep Apnea Following VNS
Neurology News Network for the week ending June 10, 2023. [WATCH TIME: 3 minutes]
CMS Adds Coverage for Antiamyloid Therapies, NDA for Migraine Agent Accepted, INTUNE Study Ahead of Schedule
Neurology News Network for the week ending June 2, 2023. [WATCH TIME: 3 minutes]
Wave Discontinues ALS Agent WVE-004, FDA Pushes Back Decision on SRP-9001, Asundexian Receives Fast Track Designation
Neurology News Network for the week ending May 27, 2023. [WATCH TIME: 3 minutes]
Treg Treatment Sustains Cognition in AD, FDA Approves Spinal Cord Stimulation Systems, Soticlestat Reduces Seizures in CDD
Neurology News Network for the week ending May 20, 2023. [WATCH TIME: 4 minutes]
CVD Risk in Epilepsy Increases Dementia Risk, Teriflunomide in RIS, FDA Clears Dry-Sensor EEG Headset
Neurology News Network for the week ending May 13, 2023. [WATCH TIME: 4 minutes]